Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 3;16(19):3387.
doi: 10.3390/cancers16193387.

Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15)

Affiliations
Review

Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15)

Natalia Krawczyk et al. Cancers (Basel). .

Abstract

Background: Idiopathic granulomatous mastitis (IGM) is a rare, benign inflammatory breast condition often mistaken for inflammatory breast cancer and, therefore, requires a biopsy for accurate diagnosis. Although not cancerous, IGM can cause emotional distress because of severe pain and ensuing breast deformity. Differentiating IGM from other breast inflammations caused by infections is essential. IGM mostly affects premenopausal women and is potentially associated with recent pregnancies and breastfeeding. The risk factors, including smoking and contraceptive use, have inconsistent associations. Steroid responses suggest an autoimmune component, though specific markers are lacking.

Methods: We performed a narrative review on potential risk factors, diagnostics, and therapy of IGM.

Results: Diagnostics and clinical management of IGM are challenging. The treatment options include NSAIDs, steroids, surgery, antibiotics, immunosuppressants, prolactin suppressants, and observation, each with varying effectiveness and side effects.

Conclusions: Current IGM treatment evidence is limited, based on case reports and small series. There is no consensus on the optimal management strategy for this disease. The GRAMAREG study by the EUBREAST Study Group aims to collect comprehensive data on IGM to improve diagnostic and treatment guidelines. By enrolling patients with confirmed IGM, the study seeks to develop evidence-based recommendations, enhancing patient care and understanding of this condition.

Keywords: breast inflammation; idiopathic granulomatous mastitis; immunosuppressants; methotrexate; steroids; surgery.

PubMed Disclaimer

Conflict of interest statement

Maggie Banys-Paluchowski has received honoraria for lectures and participation in advisory boards: Roche, Novartis, Pfizer, pfm, Eli Lilly, Onkowissen, Seagen, AstraZeneca, Eisai, AstraZeneca, Amgen, Samsung, MSD, GSK, Daiichi Sankyo, Gilead, Canon, Sirius Pintuition, and Pierre Fabre; and study support from Endomag, Mammotome, MeritMedical, Gilead, Hologic, Sirius Medical, ExactSciences. Annette Lebeau declares to have received speaker honoraria and/or personal funds for advisory role from AstraZeneca, Daiichi Sankyo, Gilead, MSD Sharp and Dohme, Myriad Genetics, Novartis, Roche, Menarini Stemline and Veracyte Inc.; writer engagement from QuIP; Steering-Committee Member of Diaceutics and Daiichi Sankyo, Inc. Other authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Typical clinical presentation in patients diagnosed with IGM.
Figure 2
Figure 2
Typical sonographic appearance of IGM: (A) heterogeneous mass with ill-defined margins, (B) multiple fluid collections with floating debris.
Figure 3
Figure 3
Study flowchart for the prospective data collection phase.

References

    1. Kessler E., Wolloch Y. Granulomatous mastitis: A lesion clinically simulating carcinoma. Am. J. Clin. Pathol. 1972;58:642–646. doi: 10.1093/ajcp/58.6.642. - DOI - PubMed
    1. Renshaw A.A., Derhagopian R.P., Gould E.W. Cystic neutrophilic granulomatous mastitis: An underappreciated pattern strongly associated with gram-positive bacilli. Am. J. Clin. Pathol. 2011;136:424–427. doi: 10.1309/AJCP1W9JBRYOQSNZ. - DOI - PubMed
    1. Idiopathic granulomatous mastitis in Hispanic women—Indiana, 2006–2008. MMWR Morb. Mortal. Wkly. Rep. 2009;58:1317–1321. - PubMed
    1. Aghajanzadeh M., Hassanzadeh R., Alizadeh Sefat S., Alavi A., Hemmati H., Esmaeili Delshad M.S., Emir Alavi C., Rimaz S., Geranmayeh S., Najafi Ashtiani M., et al. Granulomatous mastitis: Presentations, diagnosis, treatment and outcome in 206 patients from the north of Iran. Breast. 2015;24:456–460. doi: 10.1016/j.breast.2015.04.003. - DOI - PubMed
    1. Azizi A., Prasath V., Canner J., Gharib M., Sadat Fattahi A., Naser Forghani M., Sajjadi S., Farhadi E., Vasigh M., Kaviani A., et al. Idiopathic granulomatous mastitis: Management and predictors of recurrence in 474 patients. Breast J. 2020;26:1358–1362. doi: 10.1111/tbj.13822. - DOI - PubMed

LinkOut - more resources